Dabigatran etexilate 150 mg Oral Capsule
RxNorm 1037045
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1037045 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dabigatran etexilate 150 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Dabigatran etexilate 150 mg Oral Capsule
(Atom ID: 3502248)
Synonym (SY):
Dabigatran etexilate (as dabigatran etexilate mesilate) 150 mg oral capsule
(Atom ID: 12420938)
Designated preferred name (PT):
Dabigatran etexilate (as dabigatran etexilate mesylate) 150 mg oral capsule
(Atom ID: 12420941)
Synonym (SY):
Dabigatran etexilate 150 mg (dabigatran etexilate mesylate 172.95 mg) Oral Capsule
(Atom ID: 3508048)
Prescribable Name (PSN):
Dabigatran etexilate 150 mg Oral Capsule
(Atom ID: 6361092)
Full form of descriptor (FN):
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 12421819)
Patient Education
Dabigatran
Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner'). It is also used to reduce the risk of a DVT and PE from happening again after initial treatment is completed in adults and children 3 months of age and older. Dabigatran is used to help prevent DVT and PE in adults who have had hip replacement surgery. Dabigatran is also used to help prevent strokes or serious blood clots in adults who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body, and possibly causing strokes) without heart valve disease. Dabigatran is in a class of anticoagulant medications called direct thrombin inhibitors. It works by preventing blood clots from forming in the body.
[Learn More]
Blood Thinners
Blood thinners are medicines that prevent blood clots from forming. They also keep existing blood clots from getting larger. Clots in your arteries, veins, and heart can cause heart attacks, strokes, and blockages. You may take a blood thinner if you have
- Certain heart or blood vessel diseases
- An abnormal heart rhythm called atrial fibrillation
- A heart valve replacement
- A risk of blood clots after surgery
- Congenital heart defects
There are two main types of blood thinners. Anticoagulants such as heparin or warfarin (also called Coumadin) slow down your body's process of making clots. Antiplatelet drugs, such as aspirin, prevent blood cells called platelets from clumping together to form a clot.
When you take a blood thinner, follow directions carefully. Blood thinners may interact with certain foods, medicines, vitamins, and alcohol. Make sure that your health care provider knows all of the medicines and supplements you are using. You will probably need regular blood tests to check how well your blood is clotting. It is important to make sure that you're taking enough medicine to prevent clots, but not so much that it causes bleeding.
[Learn More]
* Please review the disclaimer below.
